Pulse Biosciences, Inc. Deferred Tax Assets, Goodwill and Intangible Assets
Pulse Biosciences, Inc. (PLSE) had Deferred Tax Assets, Goodwill and Intangible Assets of $544.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-02-19
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $544.00K.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $279.00K.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $99.00K.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $0.00.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $544.00K 10-K · filed 2026-02-19 |
| 2024-12-31 | $279.00K 10-K · filed 2026-02-19 |
| 2023-12-31 | $99.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |